Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The multifunctional low density lipoprotein (LDL) receptor-related protein (LRP) has been postulated to participate in a number of diverse physiological and pathological processes ranging from the homeostasis of plasma lipoproteins, atherosclerosis, and fibrinolysis to neuronal regeneration and survival. It has not been possible to demonstrate in vivo the physiological significance of LRP for each of these complex processes by a conventional gene knockout approach because LRP is essential for embryonic development. Here we have used the Cre/loxP recombination system to achieve inducible, tissue-specific and quantitative disruption of the LRP gene in adult mice. Inactivation of LRP in the livers of LDL receptor-deficient mice resulted in the accumulation of cholesterol-rich remnant lipoproteins in the circulation. In normal animals, this caused a compensatory upregulation of the LDL receptor in the liver. Conditional gene targeting has thus allowed us to isolate a specific physiological function of LRP for in vivo analysis and has provided unequivocal evidence for another LDL receptor-independent cholesterol clearance pathway in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Self-citationHerz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H., & Stanley, K. K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03306.x · Cited by 959
Self-citation
Cited by
Items 201–300 of 453
Christoffersen, C., Pedersen, T. X., Gordts, P. L. S. M., Roebroek, A., Dahlbäck, B., & Nielsen, L. B. (2010) · Circulation Research · doi:10.1161/circresaha.109.211086 · Cited by 52
Cellular Catabolism of Lipid Poor Apolipoprotein E via Cell Surface LDL Receptor-Related Protein
Narita, M., Holtzman, D. M., Fagan, A. M., LaDu, M. J., Yu, L., Han, X., Gross, R. W., Bu, G., & Schwartz, A. L. (2002) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003282 · Cited by 48
“Cellular Degradation of 125I-apoE/ –VLDL or Free 125IapoE via the LDL Receptor and/or LRP—Several lines of evidence suggest that LRP may serve as an endocytic receptor for apoE-enriched remnant particles (36, 37).”
MethodHu, L., van der Hoogt, C. C., Espirito Santo, S. M. S., Out, R., Kypreos, K. E., van Vlijmen, B. J. M., Van Berkel, T. J. C., Romijn, J. A., Havekes, L. M., van Dijk, K. W., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800130-jlr200 · Cited by 49
Basford, J. E., Moore, Z. W. Q., Zhou, L., Herz, J., & Hui, D. Y. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.194357 · Cited by 48
Self-citationRhoA of the Rho Family Small GTPases Is Essential for B Lymphocyte Development
Zhang, S., Zhou, X., Lang, R. A., & Guo, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033773 · Cited by 50
“To delete RhoA in vivo in HSCs, Mx-Cre; RhoA mice were generated by breeding RhoA mice to MxCre transgenic mice carrying a bacteriophage Cre recombinase driven by an interferon-a-inducible Mx promoter (allele symbol: Tg(Mx1cre)29-4Her [38]) (gift of Dr.”
MethodGordts, P. L. S. M., Reekmans, S., Lauwers, A., Van Dongen, A., Verbeek, L., & Roebroek, A. J. M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.192211 · Cited by 47
Brifault, C., Kwon, H., Campana, W. M., & Gonias, S. L. (2019) · Glia · doi:10.1002/glia.23599 · Cited by 47
Goldberg, I. J., Hu, Y., Noh, H. L., Wei, J. C., Huggins, L. A., Rackmill, M. G., Hamai, H., Reid, B. N., Blaner, W. S., & Huang, L. (2008) · Diabetes · doi:10.2337/db08-0083 · Cited by 52
“In the case of the Apoe / mice, circulating lipoproteins are deficient in apoE, the ligand needed for the interaction of remnant lipoproteins with both the LDL receptor and the LDL receptor–related protein (LRP).”
BackgroundInfluentialResponses to eating: lipoproteins, lipolytic products and atherosclerosis
Goldberg, I. J., Kako, Y., & Lutz, E. P. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00003 · Cited by 46
Hepatic Heparan Sulfate Proteoglycans and Endocytic Clearance of Triglyceride-Rich Lipoproteins
Foley, E. M., & Esko, J. D. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93010-x · Cited by 54
“Liver-specific ablation of Lrp1 does not result in remnant particle accumulation unless compounded with Ldlr deficiency.(14) Systemic Lrp5 null mice are viable, but do not accumulate remnant particles unless they are subjected to a high fat diet.”
BackgroundLi, Z., Li, Y., Chakraborty, M., Fan, Y., Bui, H. H., Peake, D. A., Kuo, M., Xiao, X., Cao, G., & Jiang, X.-C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042028 · Cited by 46
Kypreos, K. E., & Zannis, V. I. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500322-jlr200 · Cited by 45
“However, this study did not show any significant contribution of LRP to lipoprotein catabolism in mice.”
BackgroundInfluentialLRP1 Controls cPLA2 Phosphorylation, ABCA1 Expression and Cellular Cholesterol Export
Zhou, L., Choi, H. Y., Li, W.-P., Xu, F., & Herz, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006853 · Cited by 45
“12, n = 3 and [36]) in primary SMCs lacking LRP1.”
BackgroundResultSelf-citationModulation of the LDL receptor and LRP levels by HIV protease inhibitors
Tran, H., Robinson, S. E., MIKHAILENKO, I. A., & Strickland, D. K. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200487-jlr200 · Cited by 48
Hoekstra, M., Lammers, B., Out, R., Li, Z., Eck, M. V., & van Berkel, T. J. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800131d · Cited by 44
The Cell Biology and Physiologic Relevance of ApoE Recycling
Fazio, S., Linton, M. F., & Swift, L. L. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00033-5 · Cited by 55
“1989), and the inactivation of LRP through conditional gene targeting results in remnant lipoprotein accumulation in LDLR( 2 / 2 ) mice but not in wild-type mice (Rohlmann et al. 1998).”
BackgroundUptake of Dietary Retinoids at the Maternal-Fetal Barrier
Wassef, L., & Quadro, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253070 · Cited by 43
Intracellular lipid metabolism impairs β cell compensation during diet-induced obesity
Ye, R., Gordillo, R., Shao, M., Onodera, T., Chen, Z., Chen, S., Lin, X., SoRelle, J. A., Li, X., Tang, M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97702 · Cited by 51
Self-citationLlorente‐Cortés, V., Otero-Viñas, M., & Badimón, L. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000035391.46201.9a · Cited by 47
Maternal undernutrition programmes atherosclerosis in the ApoE*3-Leiden mouse
Yates, Z. R., Tarling, E. J., Langley‐Evans, S. C., & Salter, A. M. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508066786 · Cited by 45
“The LDLr and LRP-1 have well-established hepatic roles in the removal of pro-atherogenic lipoproteins from the plasma (27) .”
Martins, I. J., Hone, E., Chi, C., Seydel, U., Martins, R. N., & Redgrave, T. G. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32054-x · Cited by 44
Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice
Vasandani, C., Kafrouni, A. I., Caronna, A., Bashmakov, Y., Gotthardt, M., Horton, J. D., & Spady, D. K. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30120-6 · Cited by 44
Self-citationThe hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Wijers, M., Zanoni, P., Liv, N., Vos, D. Y., Jäckstein, M. Y., Smit, M., Wilbrink, S., Wolters, J. C., van der Veen, Y. T., Huijkman, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126462 · Cited by 44
Novel insights into the multifaceted and tissue‐specific roles of the endocytic receptor LRP1
Yamamoto, K., Scilabra, S. D., Bonelli, S., Jensen, A., Scavenius, C., Enghild, J. J., & Strickland, D. K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107521 · Cited by 47
Genetically modified animals in pharmacological research: future trends
Rudolph, U., & Möhler, H. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00195-8 · Cited by 49
Chen, S.-J., Sanmiguel, J., Lock, M., McMenamin, D., Draper, C., Limberis, M. P., Kassim, S. H., Somanathan, S., Bell, P., Johnston, J. C., et al. (2013) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2013.082 · Cited by 44
“ApoB48 is cleared more rapidly from the blood through processes that are independent of the LDLR, possibly explaining why LDLR -/mice do not develop significant hypercholesterolemia or atherosclerosis on a normal chow diet (Rohlmann et al., 1998).”
Shedding of Syndecan–1 From Human Hepatocytes Alters Very Low Density Lipoprotein Clearance
Deng, Y., Foley, E. M., Gonzales, J. C., Gordts, P. L. S. M., Li, Y., & Esko, J. D. (2011) · Hepatology · doi:10.1002/hep.24626 · Cited by 48
“The residual heparin lyase-insensitive component of binding/uptake presumably reflects other receptors, most likely LDL receptors and one or more members of the family of LDLR-related proteins.(3,4) Hepatocytes Shed Syndecan-1.”
BackgroundAmos, S., Mut, M., diPierro, C. G., Carpenter, J. E., Xiao, A., Kohutek, Z. A., Redpath, G. T., Zhao, Y., Wang, J., Shaffrey, M. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0030 · Cited by 43
Espirito Santo, S. M. S., Pires, N. M. M., Boesten, L. S. M., Gerritsen, G., Bovenschen, N., van Dijk, K. W., Jukema, J. W., Princen, H. M. G., Bensadoun, A., Li, W.-P., et al. (2004) · Blood · doi:10.1182/blood-2003-11-4051 · Cited by 43
Self-citationGreig, J. A., Limberis, M. P., Bell, P. L., Chen, S., Calcedo, R., Rader, D. J., & Wilson, J. M. (2017) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2017.007 · Cited by 43
“ApoB48 is cleared more rapidly from the blood through processes that are independent of LDLR, possibly explaining why Ldlr mice do not develop significant hypercholesterolemia or atherosclerosis on a normal rodent chow diet.(14) Recognizing that ApoB48 activity is a major difference between mice and humans in terms of…”
Schneider, A., Zhang, Y., Guan, Y., Davis, L. S., & Breyer, M. D. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00235.2002 · Cited by 43
“1), in accordance with previously reported results using Southern blot (3, 10, 14).”
MethodResultNeels, J. G., Horn, I. R., van den Berg, B. M. M., Pannekoek, H., & van Zonneveld, A. J. (1998) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(98)80016-7 · Cited by 47
Orth, M., Weng, W., Funke, H., Steinmetz, A., Assmann, G., Nauck, M., Dierkes, J., Ambrosch, A., Weisgraber, K. H., Mahley, R. W., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1306 · Cited by 42
Ranganathan, S., Cao, C., Catania, J., Migliorini, M., Zhang, L., & Strickland, D. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.265413 · Cited by 45
O'Reilly, M. E., Lenighan, Y. M., Dillon, E., Kajani, S., Curley, S., Bruen, R., Byrne, R., Heslin, A. M., MOLONEY, A. P., Roche, H. M., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900599 · Cited by 50
Phaneuf, D., Moscioni, A. D., LeClair, C., Raper, S. E., & Wilson, J. M. (2004) · DNA and Cell Biology · doi:10.1089/1044549041939250 · Cited by 39
“As an alternative method to induce the deletion of exon 5 of HGF/SF in vivo , homozygous Mx1-cre/HGF ex.5-flox mice bearing the cre transgene under the control of the interferon-inducible Mx1 promoter (Nagy et al ., 1993; Rohlmann et al ., 1998) were used.”
Influentialvan Vlijmen, B. J. M., Rohlmann, A., Page, S. T., Bensadoun, A., Bos, I. S. T., van Berkel, T. J. C., Havekes, L. M., & Herz, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35219 · Cited by 40
Self-citationIntracellular metabolism of triglyceride-rich lipoproteins
Heeren, J., & Beisiegel, U. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00003 · Cited by 40
Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 44
LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes
Hamlin, A. N., Basford, J. E., Jaeschke, A., & Hui, D. Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.717744 · Cited by 39
“The elevated steatosis observed in the livers of fasted hLrp1 / mice and palmitate-induced triglyceride accumulation in LRP1-deficient hepatocytes is counterintuitive, considering the well documented role of LRP1 as a chylomicron receptor responsible for the clearance of triglyceride-rich lipoproteins (35).”
BackgroundMulti-faceted role of LRP1 in the immune system
Sizova, O. S., John, L. S. S., Ma, Q., & Molldrem, J. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166189 · Cited by 41
Wohner, N., Legendre, P., Casari, C., Christophe, O. D., Lenting, P. J., & Denis, C. V. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12885 · Cited by 38
Batt, K., Patel, L., Botham, K., & Suckling, K. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0551-2 · Cited by 38
“The LRP is a multi-functional cell surface receptor which has been shown to play a part in the uptake of chylomicron remnants by the liver [39].”
BackgroundLavoie, J.-M. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i23.961 · Cited by 43
Inactivation of the proximal NPXY motif impairs early steps in LRP1 biosynthesis
Reekmans, S. M., Pflanzner, T., Gordts, P. L. S. M., Isbert, S., Zimmermann, P., Annaert, W. G., Weggen, S., Roebroek, A., & Pietrzik, C. U. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0171-7 · Cited by 40
Raffaı̈, R. L., Hasty, A. H., Wang, Y., Mettler, S. E., Sanan, D. A., Linton, M. F., Fazio, S., & Weisgraber, K. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212873200 · Cited by 36
Vos, D. Y., & van de Sluis, B. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101146 · Cited by 35
“LRP1 cooperates with LDLR in the uptake of remnant lipoproteins [107], while SR-BI mediates the uptake of CE from high-density lipoprotein particles [108].”
BackgroundLoss of Heparan N-Sulfotransferase in Diabetic Liver
Williams, K. J., Liu, M.-L., Zhu, Y., Xu, X., Davidson, W. R., McCue, P., & Sharma, K. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1116 · Cited by 31
“In the liver, lipoprotein uptake has been shown to occur via members of the LDL receptor family, particularly the LDL receptor itself (35) and the LDL receptor–related protein (36).”
BackgroundLambert, M. S., Avella, M., Berhane, Y., Shervill, E., & Botham, K. M. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02311.x · Cited by 40
Genetic determinants of obesity-related lipid traits
Sonnenberg, G. E., Krakower, G. R., Martin, L. J., Olivier, M., Kwitek, A. E., Comuzzie, A. G., Blangero, J., & Kissebah, A. H. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300474-jlr200 · Cited by 37
“A second candidate gene is the LDLrelated protein 6, which participates in the clearance and intracellular processing of TG-rich lipoproteins (36).”
BackgroundNovel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia
Shrestha, P., van de Sluis, B., Dullaart, R. P. F., & van den Born, J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.12.001 · Cited by 35
Avian apolipoprotein A-V binds to LDL receptor gene family members
Dichlberger, A., Cogburn, L. A., Nimpf, J., & Schneider, W. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.c600026-jlr200 · Cited by 33
“LDL receptor-related protein (10) and the mosaic receptor SorLA/LR11 (11).”
BackgroundHamlin, A. N., Chinnarasu, S., Ding, Y., Xian, X., Herz, J., Jaeschke, A., & Hui, D. Y. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001952 · Cited by 36
“Animals and diets – Hepatocyte-specific LRP1-null (hLrp1-/-) mice were generated by crossbreeding Lrp1flox/flox mice on a C57BL/6J background (10,26) with albumin promoter-driven recombinase transgenic mice on a C57BL/6J background (Jackson Laboratory, Bar Harbor, ME) as described previously (11).”
MethodSelf-citationMoon, J. H., Kim, H. J., Kim, H. M., Choi, S. H., Lim, S. K., Park, Y. J., Jang, H. C., & Soo, B. (2013) · Thyroid · doi:10.1089/thy.2012.0457 · Cited by 39
Gordts, P. L. S. M., Bartelt, A., Nilsson, S. K., Annaert, W., Christoffersen, C., Nielsen, L. B., Heeren, J., & Roebroek, A. J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038330 · Cited by 32
“Currently it is believed that hepatic LRP1 serves as a back-up receptor for LDLR in mediating TRL clearance as its absence in the liver in mice only affects triglyceride levels in LDLR deficiency [6].”
BackgroundInfluentialXu, W., Takahashi, Y., Sakashita, T., Iwasaki, T., Hattori, H., & Yoshimoto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105093200 · Cited by 35
Bornachea, O., Amaro, A. B., Vea, À., Nasarre, L., de Gonzalo‐Calvo, D., Escolá‐Gil, J. C., Cedó, L., Iborra, A., Martínez‐Martínez, L., Juárez, C., et al. (2020) · Theranostics · doi:10.7150/thno.37305 · Cited by 32
“In hepatic cells, LRP1 mainly interacts with ApoE-enriched lipoproteins such as chylomicrons [43].”
BackgroundSanto, S. M. S. E., Rensen, P. C. N., Goudriaan, J. R., Bensadoun, A., Bovenschen, N., Voshol, P. J., Havekes, L. M., & van Vlijmen, B. J. M. (2005) · Journal of Lipid Research · doi:10.1194/jlr.c500007-jlr200 · Cited by 34
“LDLR / ; referred to hereafter as LRP LDLR / ) (10), yielding a unique triple-knockout mouse model that lacks (conditionally) LRP, LDLR, and VLDLR (MX1Cre:LRP lox/lox LDLR / VLDLR / ; referred to hereafter as LRP LDLR / VLDLR / ).”
BackgroundMethodvan Dijk, K. W., van Vlijmen, B. J. M., van't Hof, H. B., van der Zee, A., Santamarina-Fojo, S., van Berkel, T. J. C., Havekes, L. M., & Hofker, M. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33374-5 · Cited by 31
“More recently, similar observations have been made after liver specific inactivation of the LRP gene ( 16 ).”
BackgroundEndothelium-specific depletion of LRP1 improves glucose homeostasis through inducing osteocalcin
Mao, H., Li, L., Fan, Q., Angelini, A., Saha, P. K., Coarfa, C., Rajapakshe, K., Perera, D., Cheng, J., Wu, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25673-6 · Cited by 30
Matsuo, M., Campenot, R. B., Vance, D. E., Ueda, K., & Vance, J. E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.10.004 · Cited by 34
Zhao, X., Ting, S., Sun, G., Bautista-Garrido, J., Obertas, L., & Aronowski, J. A. (2023) · Stroke · doi:10.1161/strokeaha.123.045194 · Cited by 32
Apolipoprotein E promotes lipid accumulation and differentiation in human adipocytes
Lasrich, D., Bartelt, A., Grewal, T., & Heeren, J. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.07.015 · Cited by 29
Low-density lipoprotein receptors in liver: Old acquaintances and a newcomer
Pieper‐Fürst, U., & Lammert, F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.013 · Cited by 35
Prawitt, J., Niemeier, A., Kassem, M. S., Beisiegel†, U., & Heeren, J. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.11.011 · Cited by 29
Sanchez, M. C., Chiabrando, G. A., & Vides, M. A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2329 · Cited by 28
Petit, J., Duong, M., Duvillard, L., Florentin, E., Portier, H., Lizard, G., Brun, J. M., Gambert, P., & Vergès, B. L. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00989.x · Cited by 29
LRP5 and plasma cholesterol levels modulate the canonical Wnt pathway in peripheral blood leukocytes
Borrell‐Pages, M., Carolina Romero, J., & Badimon, L. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2015.41 · Cited by 25
Yazdanyar, A., Quan, W., Jin, W., & Jiang, X. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301628 · Cited by 28
Fischer, A. W., Albers, K., Krott, L. M., Hoffzimmer, B., Heine, M., Schmale, H., Scheja, L., Gordts, P. L. S. M., & Heeren, J. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.010 · Cited by 29
“In addition to syndecan-1 and the LDLR, the LDLR-related protein 1 (LRP1) is an important endocytic receptor that is especially relevant for the uptake of postprandial chylomicron remnants [5,8,9].”
BackgroundResultFu, T., Guan, Y., Xu, J., & Wang, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.05.002 · Cited by 25
“Aplp2 -/- mice were provided by Joachim Herz (UT Southwestern) (33), and liver-specific Lrp1 KO mice were obtained from Michael Brown and Joseph Goldstein (UT Southwestern) (34).”
InfluentialZheng, X., Rivabene, R., Cavallari, C., Napolitano, M., Avella, M., Bravo, E., & Botham, K. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00830-4 · Cited by 28
“PUFA from the diet are delivered to the liver in chylomicron remnants, and the particles are taken up by receptor -mediated endocytosis via the LDL receptor (LDLr) or the LDLr-related protein (LRP) [16,25].”
BackgroundGalliano, M., Toulza, È., Jonca, N., Gonias, S. L., Serre, G., & Guerrin, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002729 · Cited by 29
“It is known that LRP1 plays an important role in lipid metabolism by binding lipoproteins (or chylomycron remnants) generated by hydrolysis of triglycerides by lipoprotein lipases [6,34,35].”
New approaches to triglyceride reduction: is there any hope left?
Filtz, A., Parihar, S., Greenberg, G. S., Park, C. M., Scotti, A., Lorenzatti, D., Badimon, J. J., Soffer, D. E., Toth, P. P., Lavie, C. J., et al. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100648 · Cited by 26
“VLDL can be cleared by VLDL receptors, LDL receptor related protein 1, and heparan sulfates, while IDLs can be cleared by both LDL receptors and LDL receptor related protein 1 [6,7] (Fig.”
BackgroundThe role of apolipoprotein A 5 in obesity and the metabolic syndrome
Zheng, X., Zhao, S., & Yan, H. (2012) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12005 · Cited by 28
“…and that both HSPG and LDLR family members function to mediate hepatic endocytosis of triglyceride-rich lipoproteins and their remnants (Ishibashi et al., 1996; Rohlmann et al., 1998; Stanford et al., 2009), it is reasonable to speculate that apoA5 could enhance hepatic uptake of these particles.”
BackgroundThe lipolysis stimulated receptor: a gene at last
Bihain, B. E., & Yen, F. T. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00006 · Cited by 31
The expression of low density lipoprotein receptor-related protein in colorectal carcinoma
Obermeyer, K., Krueger, S., Peters, B., Falkenberg, B., Roessner, A., & Röcken, C. (2007) · Oncology Reports · doi:10.3892/or.17.2.361 · Cited by 26
Endothelial function and cardiovascular diseases in HIV infected patient
Andrade, A. C. O., & Cotter, B. R. (2006) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702006000200012 · Cited by 26
“Moreover, clearance of triglycerides-rich particles does not seem to be impaired in PI-treated mice [33,34].”
BackgroundState of the art: Atherosclerosis in a limited edition
Rader, D. J., & FitzGerald, G. A. (1998) · Nature Medicine · doi:10.1038/nm0898-899 · Cited by 27
Kim, H. J., Moon, J. H., Kim, H. M., Yun, M. R., Jeon, B. H., Lee, B., Kang, E. S., Lee, H. C., & Soo, B. (2013) · Metabolism · doi:10.1016/j.metabol.2013.09.006 · Cited by 25
“In the liver, apoE-bound TG-rich lipoproteins such as VLDL and chylomicron remnant (CR) lipoprotein particles are sequestered by association with heparan sulfate proteoglycans (HSPG), and these sequestered TG-rich lipoproteins are internalized by LRP1 [7–10].”
BackgroundMatrix metalloproteinase-13 influences ERK signalling in articular rabbit chondrocytes
Raggatt, L. J., Jefcoat, S. C., Choudhury, I., Williams, S., TIKU, M. L., & Partridge, N. C. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.01.006 · Cited by 25
Tong, Y., Zhou, L., Yang, L., Guo, P., Cao, Y., Qin, F. X.-F., & Liu, J. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.062 · Cited by 26
“) administration of TLR3 agonist poly(I:C) induces IFN-I/cytokine release, resulting in an apparent systemic IFN response [22].”
BackgroundHyperlipidemia and inhibitors of HIV protease
Distler, O., Cooper, D. A., Deckelbaum, R. J., & Sturley, S. L. (2001) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200103000-00003 · Cited by 25
Schulz, S., Schagdarsurengin, U., Greiser, P., Birkenmeier, G., Müller‐Werdan, U., Hagemann, M. M., Riemann, D., Werdan, K., & Gläser, C. (2002) · Human Mutation · doi:10.1002/humu.9070 · Cited by 25
“One important characteristic is the distinct accumulation of LRP1/A2MR ligands even though a correlation between ligand concentration and receptor expression could not clearly be shown so far (Grimsley et al., 1998; Lupu et al., 1994; Rohlmann et al., 1998).”
BackgroundShen, Y., Gu, H.-M., Zhai, L., Wang, B., Qin, S., & Zhang, D. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159196 · Cited by 29
Skryabin, B. V., Holtwick, R., Fabritz, L., Kruse, M. N., Veltrup, I., Stypmann, J., Kirchhof, P. F., Sabrane, K., Bubikat, A., Vo, M., et al. (2004) · genesis · doi:10.1002/gene.20056 · Cited by 24
“; Rohlmann et al., 1998).”
Migliorini, M., Li, S.-H., Zhou, A., Emal, C. D., Lawrence, D. A., & Strickland, D. K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010449 · Cited by 24
“LRP1 was originally identified as the hepatic receptor responsible for the removal of 2-macroglobulin ( 2M) protease complexes (5, 6) and as a receptor for chylomicron remnant lipoprotein particles (7).”
BackgroundFunctional Role of the Low-Density Lipoprotein Receptor-Related Protein in Alzheimer’s Disease
Waldron, E., Jaeger, S., & Pietrzik, C. U. (2006) · Neurodegenerative Diseases · doi:10.1159/000095261 · Cited by 27
“]. Hence, the role of LRP in lipoprotein metabolism is much more restricted than that of the LDL receptor, since the latter can fully compensate for the lack of functional LRP in the liver [”
BackgroundBarcat, D., Amadio, A., Palos-Pinto, A., Daret, D., Benlian, P., Darmon, M. Y., & Bérard, A. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.11.022 · Cited by 29
Tremblay, A., Lamarche, B., Ruel, I., Hogue, J.-C., Bergeron, J., Gagné, C., & Couture, P. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.011 · Cited by 25
“Several lines of evidence have suggested that LRP plays an important role in chylomicron remnants uptake and metabolism [6,40–42].”
Background(2004) · doi:10.1016/j.bbalip.2004.03.004 · Cited by 17
González, P., Álvarez, R., Reguero, J. R., Batalla, A., Álvarez, V., Cortina, A., Cubero, G. I., Garcı́a-Castro, M., & Coto, E. (2002) · Coronary Artery Disease · doi:10.1097/00019501-200208000-00001 · Cited by 24
van Dijk, K. W., Hofker, M. H., & Havekes, L. M. (1999) · Current Atherosclerosis Reports · doi:10.1007/s11883-999-0005-y · Cited by 28
Lipid nanoparticle screening in nonhuman primates with minimal loss of life
Zenhausern, R., Jang, B., Echeverri, E. S., Gentry, K., Calkins, R., Curran, E. H., Wood, J., Stammen, R. L., Loughrey, D., Chappa, P., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02711-y · Cited by 39
Vergés, M., Bensadoun, A., Herz, J., Belcher, J. D., & Havel, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312908200 · Cited by 23
Self-citationWu, Y., Wang, M., Yang, T., Qin, T.-Y., Qin, L., Hu, Y.-M., Zhang, C.-F., Sun, B., Ding, L., Wu, L., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.794841 · Cited by 24
“Analysis of the proteome showed that AC significantly upregulated LDLR and AL significantly upregulated LDLR and LRP1, which mediated the clearance of TG- and cholesterol ester-containing lipoproteins including LDL and chylomicrons (76, 77).”
BackgroundXu, G., Green, C. C., Fromholt, S. E., & Borchelt, D. R. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt110 · Cited by 22
“Mice with targeted Lox P sites introduced into intronic and promoter regions of the LRP1 gene were obtained from Joachim Herz [28,29], called LRP1 lox/lox.”
Clearance of coagulation factor VIII in very low‐density lipoprotein receptor knockout mice
Bovenschen, N., van Dijk, K. W., Havekes, L. M., Mertens, K., & van Vlijmen, B. J. M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05093.x · Cited by 22
“Mice carrying loxP siteswithin the LRP gene (LRPflox/flox) and/or transgenic for cre-recombinase (MX1cre+) (Rohlmann et al, 1998) were combined with VLDLR knockout mice (VLDLR)/)) (Frykman et al, 1995), resulting in LRPflox/flox (controls), MX1cre+ LRPflox/flox (LRP)), LRPflox/flox VLDLR)/)…”
MethodDichek, H. L., Qian, K., & Agrawal, N. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300459-jlr200 · Cited by 23
“The LRP removes mainly apoB-48-containing lipoproteins (38).”
Igel, E., Haller, A. M., Wolfkiel, P. R., Orr–Asman, M. A., Jaeschke, A., & Hui, D. Y. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101106 · Cited by 20
“ApoE synthesized in hepatocytes is secreted into the plasma circulation, where it serves as the ligand that mediates lipoprotein binding to low-density lipoprotein (LDL) receptor family proteins and cell surface heparan sulfate proteoglycans for the clearance of triglyceride-rich lipoproteins from the plasma circulati…”
Background
Metadata
- Authors
- Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Max Delbrück Center (DE)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-02-01
- Volume
- 101
- Issue
- 3
- Pages
- 689-695
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508614
- OpenAlex
- W2067089828
- Cited by
- 455
- References
- 33
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 14 · 2021: 13 · 2020: 9 · 2019: 9 · 2018: 18 · 2017: 15 · 2016: 14 · 2015: 16 · 2014: 8 · 2013: 17 · 2012: 19
- FWCI
- 33.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- LDL receptor-related protein, LRP, chylomicron remnants, cholesterol clearance, LDL receptor, conditional gene targeting, Cre-loxP recombination, liver, LDL receptor-deficient mice, lipoprotein metabolism
- MeSH terms
- Animals, Chylomicrons, Liver, Mice, Inbred C57BL, Mice, Transgenic, Receptors, Immunologic, Receptors, LDL, Recombination, Genetic, Viral Proteins, Mice, Knockout, Integrases, Low Density Lipoprotein Receptor-Related Protein-1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.